49 related articles for article (PubMed ID: 27770477)
21. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
23. Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1-specific IgE binding of birch pollen.
Seutter von Loetzen C; Reuter A; Spiric J; Schulenborg T; Bellinghausen I; Völker E; Vogel L; Rösch P; Schiller D
Clin Exp Allergy; 2019 May; 49(5):712-723. PubMed ID: 30706562
[TBL] [Abstract][Full Text] [Related]
24. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
25. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
26. IgE and allergen-specific immunotherapy-induced IgG
Groh N; von Loetzen CS; Subbarayal B; Möbs C; Vogel L; Hoffmann A; Fötisch K; Koutsouridou A; Randow S; Völker E; Seutter von Loetzen A; Rösch P; Vieths S; Pfützner W; Bohle B; Schiller D
Clin Exp Allergy; 2017 May; 47(5):693-703. PubMed ID: 27770477
[TBL] [Abstract][Full Text] [Related]
27. Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen.
Grönlund H; Gafvelin G
Hum Vaccin; 2010 Dec; 6(12):970-7. PubMed ID: 21157177
[TBL] [Abstract][Full Text] [Related]
28. Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity Reactions.
James LK; Till SJ
Curr Allergy Asthma Rep; 2016 Mar; 16(3):23. PubMed ID: 26892721
[TBL] [Abstract][Full Text] [Related]
29. The clinical significance of allergen-specific IgG4 in allergic diseases.
Qin L; Tang LF; Cheng L; Wang HY
Front Immunol; 2022; 13():1032909. PubMed ID: 36389804
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of immunotherapy: IgG revisited.
Wachholz PA; Durham SR
Curr Opin Allergy Clin Immunol; 2004 Aug; 4(4):313-8. PubMed ID: 15238798
[TBL] [Abstract][Full Text] [Related]
31. Precision engineering for localization, validation, and modification of allergenic epitopes.
Pomés A; Smith SA; Chruszcz M; Mueller GA; Brackett NF; Chapman MD
J Allergy Clin Immunol; 2024 Mar; 153(3):560-571. PubMed ID: 38181840
[TBL] [Abstract][Full Text] [Related]
32. The Multifaceted B Cell Response in Allergen Immunotherapy.
Jiménez-Saiz R; Patil SU
Curr Allergy Asthma Rep; 2018 Oct; 18(12):66. PubMed ID: 30291463
[TBL] [Abstract][Full Text] [Related]
33. The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer.
Bianchini R; Karagiannis SN; Jordakieva G; Jensen-Jarolim E
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708690
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
